DK0941322T3 - Bovint laktationsassocieret immunotropt protein (CD14), kodende gen og anvendelse i B-celleaktivering - Google Patents

Bovint laktationsassocieret immunotropt protein (CD14), kodende gen og anvendelse i B-celleaktivering

Info

Publication number
DK0941322T3
DK0941322T3 DK97913053T DK97913053T DK0941322T3 DK 0941322 T3 DK0941322 T3 DK 0941322T3 DK 97913053 T DK97913053 T DK 97913053T DK 97913053 T DK97913053 T DK 97913053T DK 0941322 T3 DK0941322 T3 DK 0941322T3
Authority
DK
Denmark
Prior art keywords
protein
lait
cells
bovine
immunotropic
Prior art date
Application number
DK97913053T
Other languages
Danish (da)
English (en)
Inventor
Michael H Julius
Dominik Filipp
Kamel Alizadeh-Khiavi
Original Assignee
Arthritis & Autoimmunity Res C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arthritis & Autoimmunity Res C filed Critical Arthritis & Autoimmunity Res C
Application granted granted Critical
Publication of DK0941322T3 publication Critical patent/DK0941322T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/801—Pediatric

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK97913053T 1996-11-18 1997-11-18 Bovint laktationsassocieret immunotropt protein (CD14), kodende gen og anvendelse i B-celleaktivering DK0941322T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/746,883 US6093693A (en) 1996-11-18 1996-11-18 B cell activation
PCT/CA1997/000880 WO1998022580A2 (en) 1996-11-18 1997-11-18 Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation

Publications (1)

Publication Number Publication Date
DK0941322T3 true DK0941322T3 (da) 2007-06-25

Family

ID=25002765

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97913053T DK0941322T3 (da) 1996-11-18 1997-11-18 Bovint laktationsassocieret immunotropt protein (CD14), kodende gen og anvendelse i B-celleaktivering

Country Status (16)

Country Link
US (4) US6093693A (pl)
EP (2) EP1801216A3 (pl)
JP (1) JP4447058B2 (pl)
CN (1) CN100516215C (pl)
AT (1) ATE356205T1 (pl)
AU (1) AU732476B2 (pl)
BR (1) BR9713096A (pl)
CA (1) CA2272051C (pl)
CZ (1) CZ300752B6 (pl)
DE (1) DE69737456T2 (pl)
DK (1) DK0941322T3 (pl)
ES (1) ES2284183T3 (pl)
HU (1) HU226217B1 (pl)
IL (1) IL129855A (pl)
PL (1) PL193670B1 (pl)
WO (1) WO1998022580A2 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID26730A (id) * 1998-05-27 2001-02-01 Gemma Biotechnology Ltd Induksi protein-protein dan peptida-peptida antibiotik oleh lait/scd14-protein
CA2347069A1 (en) * 1998-10-20 2000-04-27 Societe Des Produits Nestle S.A. Protein for treatment or prevention of a gastrointestinal tract disorder
EP1111388A1 (en) * 1999-12-23 2001-06-27 Universiteit Gent Interaction between CD14 and HBV components
US6984503B1 (en) * 2002-06-27 2006-01-10 The United States Of America As Represented By The Secretary Of The Agriculture Use of recombinant bovine CD14 in the treatment and prevention of coliform mastitis in dairy cows
KR101089704B1 (ko) * 2003-03-11 2011-12-07 리젠 테라퓨틱스 피엘씨 초유로부터 펩티드의 정제
ES2232273B1 (es) * 2003-03-21 2006-07-16 Jose Manuel Fernandez-Real Lemos Nuevas aplicaciones terapeuticas de la glucoproteina cd14s.
US20060134190A1 (en) * 2004-12-16 2006-06-22 Banner Pharmacaps Inc. Formulations of bisphosphonate drugs with improved bioavailability

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543303A (en) * 1988-11-28 1996-08-06 Goyert; Sanna M. Recombinant myelomonocytic differentiation antigen CD14
AU645515B2 (en) * 1989-08-01 1994-01-20 Rockefeller University, The Methods and compositions for ameliorating the symptoms of sepsis
EP0634935A4 (en) 1992-04-06 1996-01-31 North Shore Univ Hospital A NEW THERAPY OF SEPSIS BY MEANS OF A SOLUBLE FORM OF RECOMBINANT CD14 MYELOMONOCYTIC ANTIGEN.
WO1994028025A1 (en) * 1993-05-28 1994-12-08 The Scripps Research Institute Methods and compositions for inhibiting cd14 mediated cell activation
US5932536A (en) 1994-06-14 1999-08-03 The Rockefeller University Compositions for neutralization of lipopolysaccharides
US5714469A (en) * 1994-09-01 1998-02-03 Smithkline Beecham Corporation Method of treating sepsis
US5766593A (en) * 1994-12-30 1998-06-16 Amgen Inc. Anti-inflammatory CD14 peptides
WO1996020957A1 (en) * 1994-12-30 1996-07-11 Amgen Inc. Anti-inflammatory cd14 polypeptides
AU5688596A (en) * 1995-04-13 1996-10-30 Deutsche Om Arzneimittel Gmbh Anti-cd14 antibodies for use in the induction of il-10 secre tion
US6168787B1 (en) * 1995-04-24 2001-01-02 John Wayne Cancer Institute Pluripotent vaccine against enveloped viruses
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof

Also Published As

Publication number Publication date
CN100516215C (zh) 2009-07-22
HUP0001057A3 (en) 2002-09-30
CA2272051C (en) 2012-09-18
BR9713096A (pt) 2000-10-24
EP0941322B1 (en) 2007-03-07
CZ300752B6 (cs) 2009-08-05
EP1801216A2 (en) 2007-06-27
US6093693A (en) 2000-07-25
WO1998022580A3 (en) 1998-10-01
CN1238010A (zh) 1999-12-08
DE69737456D1 (de) 2007-04-19
AU5045198A (en) 1998-06-10
ATE356205T1 (de) 2007-03-15
IL129855A0 (en) 2000-02-29
WO1998022580A2 (en) 1998-05-28
HU226217B1 (en) 2008-06-30
EP1801216A3 (en) 2007-11-07
PL193670B1 (pl) 2007-03-30
JP4447058B2 (ja) 2010-04-07
JP2001504695A (ja) 2001-04-10
DE69737456T2 (de) 2007-11-29
US20070014809A1 (en) 2007-01-18
CZ175199A3 (cs) 1999-11-17
PL333413A1 (en) 1999-12-06
AU732476B2 (en) 2001-04-26
IL129855A (en) 2013-06-27
US6676985B1 (en) 2004-01-13
EP0941322A2 (en) 1999-09-15
CA2272051A1 (en) 1998-05-28
ES2284183T3 (es) 2007-11-01
HUP0001057A2 (hu) 2000-08-28
US20040258704A1 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
EP0210189A4 (en) RECOMBINANT ALVEOLAR SURFACE ACTIVE PROTEIN.
GB9224584D0 (en) Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases
NZ223506A (en) Tissue factor protein, dna encoding it, vectors, host cells, production of the protein and pharmaceutical compositions
Schijns et al. Immunoadjuvant activities of E. coli-and plasmid-expressed recombinant chicken IFN-α/β, IFN-γ and IL-1β in 1-day-and 3-week-old chickens
GEP20022695B (en) Moraxella Catarrhalis Outer Membrane Protein-106 Polypeptide, Gene Sequence and Uses Thereof
EP0861894A4 (en) POLYPEPTIDE THAT SUPPRESSES DIFFERENTIATION
EP0192392A3 (en) Insulin receptor, its purification, its production in recombinant cells, dna therefor, antibodies to insulin receptor and their preparation, and pharmaceutical compositions containing them
ATE105869T1 (de) Formen des koloniestimulierungsfaktors 1.
EP0855918A4 (en) INTERLEUKIN-15 FROM CHICKEN AND USES THEREOF
IL82364A (en) Recombinant expression system for producing alveolar surfactant protein (asp) encoded by human sp-18, human sp-5 or canine sp-5 dna; recombinant asp produced thereby and pharmaceutical compositions containing the recombinant asp
DK0941322T3 (da) Bovint laktationsassocieret immunotropt protein (CD14), kodende gen og anvendelse i B-celleaktivering
CA2171611A1 (en) Analog of haemophilus hin47 with reduced protease activity
EP0236977A3 (en) Bovine virus diarrhea and hog cholera vaccines
EP0770137A4 (en) IMPROVEMENTS IN PROTEIN PRODUCTION IN HOST CELLS
NO890174L (no) Rekombinante interleukin-1alfa-polypeptider.
NZ505350A (en) DNA encoding a tumour antigen peptide (43 kDa) for diagnosis or treatment of tumours
GB9910375D0 (en) Vaccine composition
KIYONO et al. Oral Adjuvants Which Enhance or Replace T Cells for IgA Responses